Stemline Therapeutics, Inc. (NASDAQ: STML) today announced the pricing of an underwritten public offering of 8,888,889 shares of its common ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Stemline Therapeutics Announces Upsizing and Pricing of $80 Million Public Offering of Common StockJanuary 15, 2019 10:04 PM Pre-Open Stock Movers 01/15: (BGFV) (APRN) (PLAY) Higher; (BPTH) (PCG) (TSLA) (SHW) Lower (more...)January 15, 2019 9:16 AM After-Hours Movers 01/14: (BGFV) (PLAY) (GNW) Higher; (BPTH) (ALNY) (STML) (more...)January 14, 2019 5:18 PM Stemline Therapeutics (STML) Announces 6.6M Share Proposed Public Offering of Common StockJanuary 14, 2019 4:35 PM